SHELLEY PAYNE: Open Payments
NPI 1306830468 · BRYANT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 36 payments from 15 companies in 2025. Trend: 2023 $301 · 2024 $444 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $126 |
| Globus Medical, Inc. | 1 | $99 |
| PFIZER INC. | 4 | $71 |
| ABBVIE INC. | 3 | $57 |
| Dexcom, Inc. | 3 | $53 |
| Novo Nordisk Inc | 3 | $49 |
| Exact Sciences Corporation | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Abbott Laboratories | 1 | $22 |
Products named: MOUNJARO, Senza, Dexcom G6 Transmitter, UBRELVY, ELIQUIS, TRELEGY ELLIPTA, Rybelsus, NURTEC ODT.
Industry payments across AR — which companies pay providers there.
